Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study.
Breslow depth
immunotherapy
mucosal melanoma
prognostic factors
somatic mutations
survival outcomes
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Jan 2024
03 Jan 2024
Historique:
received:
20
11
2023
revised:
22
12
2023
accepted:
25
12
2023
medline:
11
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
epublish
Résumé
Mucosal melanoma (MM) is an uncommon melanoma subtype affecting mucosal surfaces of the head and neck, anorectal region, and vulvovaginal area. We aimed to present our experience at a tertiary-level hospital regarding MM diagnosis, management, monitoring of progression, mutations, and outcome predictors. We performed a registry-based cohort study including MM cases diagnosed from 2012 to 2022 and retrospectively characterized somatic mutations on
Identifiants
pubmed: 38201654
pii: cancers16010227
doi: 10.3390/cancers16010227
pii:
doi:
Types de publication
Journal Article
Langues
eng